Granules India's shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing ...

Granules added that manufacturing and distribution of its existing products at the facility will continue unaffected.

"On February 26, 2025, the US FDA issued a Warning Letter to Granules' Gagillapur facility based on its inspection conducted ...

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...

Drug firm Granules India Ltd on Thursday (February 27) announced that the US FDA has issued a Warning Letter for its ...

Discover how waste plastic bags undergo a precise recycling process to create high-quality granules used in the automotive industry. The transformation begins with shredding and melting, followed by ...

The Warning Letter is dated February 26, 2025 and the facility continues to hold an "Official Action Indicated" (OAI) status.

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...

New research suggests that the formation of stress granules, clumps of proteins and RNA under stress, is a potential root ...

Shares of Granules India tumbled nearly 8 percent in intra-day trade on February 28, 2025, after the United States Food and Drug Administration (US FDA) issued a warning letter to the company’s ...